Conti F - Search Results

1

Dexrazoxane cardioprotection in advanced breast cancer patients undergoing high-dose epirubicin treatment.

Vici P, Ferraironi A, Di Lauro L, Carpano S, Conti F, Belli F, Paoletti G, Maini CL, Lopez M. Vici P, et al. Among authors: conti f. Clin Ter. 1998 Jan-Feb;149(921):15-20. Clin Ter. 1998. PMID: 9621483 Review.

2

Intrapatient comparison of single-agent epirubicin with or without lonidamine in metastatic breast cancer.

Lopez M, Vici P, Di Lauro L, Paoletti G, Gionfra T, Conti F, Carpano S, Pignatti F, Giannarelli D. Lopez M, et al. Among authors: conti f. Eur J Cancer. 1995 Sep;31A(10):1611-4. doi: 10.1016/0959-8049(95)00200-3. Eur J Cancer. 1995. PMID: 7488410 Clinical Trial.

3

Vinorelbine and mitomycin C in anthracycline-pretreated patients with advanced breast cancer.

Vici P, Di Lauro L, Carpano S, Amodio A, Pignatti F, Casali A, Conti F, Lopez M. Vici P, et al. Among authors: conti f. Oncology. 1996 Jan-Feb;53(1):16-8. doi: 10.1159/000227528. Oncology. 1996. PMID: 8570125 Clinical Trial.

4

Paclitaxel activity in anthracycline refractory breast cancer patients.

Vici P, Di Lauro L, Conti F, Capomolla E, Gionfra T, Amodio A, Lopez M. Vici P, et al. Among authors: conti f. Tumori. 1997 May-Jun;83(3):661-4. doi: 10.1177/030089169708300307. Tumori. 1997. PMID: 9267484 Clinical Trial.

5

Randomized prospective clinical trial of high-dose epirubicin and dexrazoxane in patients with advanced breast cancer and soft tissue sarcomas.

Lopez M, Vici P, Di Lauro K, Conti F, Paoletti G, Ferraironi A, Sciuto R, Giannarelli D, Maini CL. Lopez M, et al. Among authors: conti f. J Clin Oncol. 1998 Jan;16(1):86-92. doi: 10.1200/JCO.1998.16.1.86. J Clin Oncol. 1998. PMID: 9440727 Clinical Trial.

6

Clinical relevance of radionuclide angiography and antimyosin immunoscintigraphy for risk assessment in epirubicin cardiotoxicity.

Maini CL, Sciuto R, Ferraironi A, Vici P, Tofani A, Festa A, Conti F, Lopez M. Maini CL, et al. Among authors: conti f. J Nucl Cardiol. 1997 Nov-Dec;4(6):502-8. doi: 10.1016/s1071-3581(97)90008-8. J Nucl Cardiol. 1997. PMID: 9456190

7

[Vinorelbin in the treatment of breast cancer: current status and prospectives for the future].

Conti F, Vici P. Conti F, et al. Clin Ter. 1998 Jan-Feb;149(921):61-74. Clin Ter. 1998. PMID: 9621491 Review. Italian.

8

[Simultaneous infusion of vinorelbin and taxol as first-line chemotherapy in metastasized breast cancer].

Vici P, Conti F, Amodio A, Belli F, Della Giulia M, Mariotti S, Gionfra T, Lopez M. Vici P, et al. Among authors: conti f. Clin Ter. 1998 Jul-Aug;149(4):255-9. Clin Ter. 1998. PMID: 9866885 Italian.

9

[Gemcitabine in advanced stage soft tissue sarcoma: a phase II study].

Amodio A, Carpano S, Manfredi C, Del Monte G, Di Lauro L, Gionfra T, Conti F, Paoletti G, Lopez M. Amodio A, et al. Among authors: conti f. Clin Ter. 1999 Jan-Feb;150(1):17-20. Clin Ter. 1999. PMID: 10367540 Review. Italian.

10

First-line chemotherapy with vinorelbine and paclitaxel as simultaneous infusion in advanced breast cancer.

Vici P, Amodio A, Di Lauro L, Conti F, Gionfra T, Belli F, Lopez M. Vici P, et al. Among authors: conti f. Oncology. 2000;58(1):3-7. doi: 10.1159/000012071. Oncology. 2000. PMID: 10644933 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,516 results

Search Page

Filters